Steward Partners Investment Advisory’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $830 | Hold |
100
| – | – | ﹤0.01% | 4213 |
|
|
2025
Q4 | $1.24K | Hold |
100
| – | – | ﹤0.01% | 4056 |
|
|
2025
Q3 | $882 | Hold |
100
| – | – | ﹤0.01% | 4064 |
|
|
2025
Q2 | $638 | Hold |
100
| – | – | ﹤0.01% | 3938 |
|
|
2025
Q1 | $486 | Hold |
100
| – | – | ﹤0.01% | 3865 |
|
|
2024
Q4 | $956 | Hold |
100
| – | – | ﹤0.01% | 3763 |
|
|
2024
Q3 | $835 | Hold |
100
| – | – | ﹤0.01% | 3546 |
|
|
2024
Q2 | $682 | Hold |
100
| – | – | ﹤0.01% | 3440 |
|
|
2024
Q1 | $253 | Hold |
100
| – | – | ﹤0.01% | 3463 |
|
|
2023
Q4 | $240 | Hold |
100
| – | – | ﹤0.01% | 3400 |
|
|
2023
Q3 | $340 | Hold |
100
| – | – | ﹤0.01% | 3270 |
|
|
2023
Q2 | $735 | Hold |
100
| – | – | ﹤0.01% | 3163 |
|
|
2023
Q1 | $1.04K | Hold |
100
| – | – | ﹤0.01% | 3117 |
|
|
2022
Q4 | $1.18K | Sell |
100
-500
| -83% | -$7.74K | ﹤0.01% | 3106 |
|
|
2022
Q3 | $13K | Buy |
600
+500
| +500% | +$13.9K | ﹤0.01% | 2410 |
|
|
2022
Q2 | $3K | Sell |
100
-16
| -14% | -$546 | ﹤0.01% | 2904 |
|
|
2022
Q1 | $5K | Hold |
116
| – | – | ﹤0.01% | 2873 |
|
|
2021
Q4 | $5K | Sell |
116
-922
| -89% | -$41.7K | ﹤0.01% | 2808 |
|
|
2021
Q3 | $52K | Sell |
1,038
-50
| -5% | -$3.03K | ﹤0.01% | 1869 |
|
|
2021
Q2 | $69K | Sell |
1,088
-182
| -14% | -$11.7K | ﹤0.01% | 2749 |
|
|
2021
Q1 | $118K | Buy |
1,270
+1,154
| +995% | +$118K | ﹤0.01% | 1538 |
|
|
2020
Q4 | $10K | Hold |
116
| – | – | ﹤0.01% | 2302 |
|
|
2020
Q3 | $12K | Sell |
116
-200
| -63% | -$21.6K | ﹤0.01% | 2065 |
|
|
2020
Q2 | $25K | Buy |
316
+216
| +216% | +$16.1K | ﹤0.01% | 1689 |
|
|
2020
Q1 | $5K | Hold |
100
| – | – | ﹤0.01% | 2070 |
|
|
2019
Q4 | $5K | Hold |
100
| – | – | ﹤0.01% | 2226 |
|
|
2019
Q3 | $5K | Hold |
100
| – | – | ﹤0.01% | 2231 |
|
|
2019
Q2 | $4K | Buy |
+100
| New | +$4.79K | ﹤0.01% | 2266 |
|
|
2018
Q4 | – | Sell |
-100
| Closed | -$7K | – | 1117 |
|
|
2018
Q3 | $7K | Hold |
100
| – | – | ﹤0.01% | 2006 |
|
|
2018
Q2 | $5K | Hold |
100
| – | – | ﹤0.01% | 1971 |
|
|
2018
Q1 | $5K | Hold |
100
| – | – | ﹤0.01% | 1775 |
|
|
2017
Q4 | $4K | Hold |
100
| – | – | ﹤0.01% | 1558 |
|
|
2017
Q3 | $4K | Hold |
100
| – | – | ﹤0.01% | 1344 |
|
|
2017
Q2 | $3K | Hold |
100
| – | – | ﹤0.01% | 1331 |
|
|
2017
Q1 | $2K | Hold |
100
| – | – | ﹤0.01% | 1297 |
|
|
2016
Q4 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 711 |
|
Other funds holding EBS
VCM
PCM
VPM
Steward Partners Investment Advisory's EBS Position: Q1 2026 in Review
Steward Partners Investment Advisory held its Emergent Biosolutions (EBS) position steady in Q1 2026 at 100 shares worth $830. The position accounts for ﹤0.01% of the portfolio, ranked #4213.
Steward Partners Investment Advisory first reported a position in EBS in Q4 2016 and has held it in 36 quarters since. The position peaked at $118K in Q1 2021. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.
- Steward Partners Investment Advisory held 100 shares of Emergent Biosolutions worth $830 as of Q1 2026.
- Steward Partners Investment Advisory left its Emergent Biosolutions share count unchanged in Q1 2026.
- Emergent Biosolutions made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #4213 holding.
- Steward Partners Investment Advisory first reported a position in Emergent Biosolutions in Q4 2016 and has held it in 36 quarters since.
- Steward Partners Investment Advisory's Emergent Biosolutions position peaked at $118K in Q1 2021.
- 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.
Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.